
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) Has Succeeded In Generating Interest In 2023, The Stock Is Down -82.88% Year-To-Date
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)’s traded shares stood at 1.67 million during the last session, with the company’s beta value hitting 1.95. At the close of